Combination therapy to treat hepatitis B virus infection

摘要

The present invention is a method of treating hepatitis B virus (HBV) infection in a subject in need thereof, the subject being directed to a tumor necrosis factor receptor superfamily (TNFRSF) agonist (eg, a receptor). One of HBV infections in a subject by administration of a combination drug of an agonist antibody, but not limited to a soluble TNFRSF agonist containing its natural ligand, or a fragment thereof) and interferon (IFN) or a functional fragment thereof. Concerning methods involving reducing one or more symptoms.